Lower dose of newer clot-buster may be appropriate for some stroke patients
New research confirms that the lower 0.25mg/kg dose of the clot-busting agent tenecteplase is appropriate for eligible stroke patients and can reduce the need for mechanical clot removal, according to late breaking science ...
Feb 20, 2020
0
8